| Structure | Chemical Name | CAS | MF |
|
Cefepime sulfate
|
107648-78-2
|
C19H25N6O5S2.HO4S
|
|
CEFEPIME HYDROCHLORIDE (NONSTERILE)
|
|
|
|
|
Cefepime + L - Arginine
|
|
|
|
C3D PEPTIDE P16
|
|
C86H131N25O27
|
|
Cefepime hydrochloride
|
123171-59-5
|
C19H28Cl2N6O6S2
|
|
Cefepime
|
88040-23-7
|
C19H24N6O5S2
|
|
|
CEFEPINE
|
|
|
|
Cefeprime dihydrochloride
|
107648-80-6
|
C19H25ClN6O5S2
|
|
C3D PEPTIDE P16
|
99027-06-2
|
C86H131N25O27
|
|
|
CefepimeKetorolacTromethamineSibutramine
|
|
|
|
|
Ceferoxime acid
|
|
|
|
2-Cefetamet Pivoxil
|
126617-54-7
|
C20H25N5O7S2
|
|
|
CEFETAMET PIVALOYLMETHYL ESTER HYDROCHLORIDE
|
|
|
|
|
Cefetamet pivoxil Hydrochloride oral
|
|
|
|
Cefetamet pivoxil hydrochloride
|
111696-23-2
|
C20H26ClN5O7S2
|
|
Cefetamet pivoxyl
|
65243-33-6
|
C20H25N5O7S2
|
|
Cefetamet hydrochloride
|
65052-63-3
|
C14H15N5O5S2
|
|
CEFETAMET PIVOXIL
|
|
C20H25N5O7S2
|
|
|
CD3 (PE-Texas Red)
|
|
|
|
Cefetrizole
|
65307-12-2
|
C16H15N5O4S3
|
|
|
CDP-ethanolamine-ceramide ethanolaminephosphotransferase
|
|
|
|
Cefetecol
|
117211-03-7
|
C20H17N5O9S2
|
|
|
CDOP protocol
|
|
|
|
|
CDO protein
|
|
|
|
|
CEE protocol
|
|
|
|
|
CD165,PG37,37KD,CLONE:SN2,MABANTI-HUMAN:FROZEN,IH/FLOW
|
|
|
|
|
CD34,PHAGOCYTIC,MABANTI-HUMAN,FITC
|
|
|
|
|
CDP-glucose oxidoreductase
|
|
|
|
|
CDPglycerol glycerophosphotransferase
|
9076-71-5
|
|
|
|
CDP-glucose 4,6-dehydratase
|
37259-55-5
|
|
|
|
c(DPhe-His-Trp-Ala-Val-Gly-His-Leu-Leu)
|
|
|
|
|
C(11)-D2-PHEN
|
|
|
|
|
Cdp-HexanolamineAgarose
|
|
|
|
|
CD41,PGPIIB-IIIA,CLONE:HUPC-M1/290AS-10,MABANTI-HUMAN,PE
|
|
|
|
|
CD36,PGPIV/IIIB,MONOCYTE,MACROPHAGE,CLONE:SMMABANTI-HUMAN
|
|
|
|
|
CD41,PGPIIB/IIIA,CLONE:5B12,MABANTI-HUMAN,RPE:FLOW
|
|
|
|
|
CD41,PGPIIB/IIIA,GP125-110-25,CLONE:CLB-THROMB/7,MABANTI-HUMAN
|
|
|
|
|
CD36,PGPIV/IIIB,MONOCYTE,GP90,CLONE:CLB-IVC7,MABANTI-HUMAN
|
|
|
|
|
CD36,PGPIV/IIIB,MONOCYTE,GP90,CLONE:CLB-IVC7,MABANTI-HUMAN,FITC
|
|
|
|
|
CD41,PGPIIB/IIIA,GP125-110-25,CLONE:CLB-THROMB/7,MABANTI-HUMAN,FITC
|
|
|
|
|
CD41,PGPIIB/IIIA,CLONE:5B12,MABANTI-HUMAN,FITC
|
|
|
|
|
Cefidinir
|
|
|
|
|
CD117, phosphorylated (Tyr936) (PE/Cy5)
|
|
|
|
|
CD117, phosphorylated (pTyr719) (c-kit, Stem Cell Factor, SCF Receptor, Steel Factor Receptor, Mast Cell Growth Factor, MGF)
|
|
|
|
|
Cefipime-HCL (Sterile,Non-Sterile with or without Arginine Buffer)
|
|
|
|
|
cefipime
|
|
|
|
|
cefipirome
|
|
|
|
|
Cefirome
|
|
|
|
[2'-13C]CYTIDINE
|
478511-19-2
|
C9H13N3O5
|
|
[1',2',3',4',5'-13C5]CYTIDINE
|
|
C9H13N3O5
|
|
CEGABA
|
4386-03-2
|
C7H13NO4
|
|
Cefivitril
|
66474-36-0
|
C15H15N7O4S3
|
|
Cefixime-13C,15N2
|
|
C16H15N5O7S2
|
|
|
Cefixime,Ceftizoxime,Azithromycin,Terbinafine,Cilo
|
|
|
|
|
CEFIXIMUMCEFNIXIME
|
|
|
|
cefixime
|
108691-83-4
|
C16H15N5O7S2
|
|
|
Cefixime
|
|
|
|
Cefixime
|
79350-37-1
|
C16H15N5O7S2
|
|
|
Cefixime trihydrate Oral
|
|
|
|
|
Cefixime Diester / for Cefixime
|
|
|
|
|
Cefixime powder
|
|
|
|
|
Cefixime(for capsule)
|
|
|
|
|
Cefixime USP/EP
|
|
|
|
|
CefiximeDispersableTablet
|
|
|
|
|
CefiximePowderForSuspension
|
|
|
|
|
CDP-4-keto-6-deoxy-D-glucose-3-dehydrase
|
|
|
|
|
CD9, Platelet p24, Clone: P1/33/2, Mab anti-Human
|
|
|
|
|
CD9, Platelet, gp24, Clone: CLB-thromb/8, Mab anti-Human
|
|
|
|
|
CD38,PLASMACELL,RATMABANTI-MOUSE
|
|
|
|
|
CD9,PLATELET,B-CELL(PRE-),CLONE:K41,MABANTI-HUMAN:FROZEN/PARAFFIN,IH/FLOW/WB
|
|
|
|
|
CD38,PLASMACELL,T10ANTIGEN,CLONE:T16,MABANTI-HUMAN
|
|
|
|
|
CD9,PLATELETP24,CLONE:P1/33/2,MABANTI-HUMAN,FITC:FLOW
|
|
|
|
|
CD61,PLATELETGLYCOPROTEINIIIA,110KD,CLONE:Y2/51,MABANTI-HUMAN:FROZEN/PARAFFIN
|
|
|
|
|
CD61,PLATELETGLYCOPROTEINIIIA,105KD,CLONE:2F2,MABANTI-HUMAN:FROZEN/PARAFFIN,IH/NOWB
|
|
|
|
|
CD38,PLASMACELL,T10ANTIGEN,45KD,CLONE:B307(AT1),MABANTI-HUMAN:FROZEN/NOPARAFFIN
|
|
|
|
|
CD38,PLASMACELL,RATMABANTI-MOUSE,FITC
|
|
|
|
|
CD38,PLASMACELL,CLONE:AT13/5,MABANTI-HUMAN,RPE
|
|
|
|
|
CD138,PLASMOCYTE,SYNDECAN-1,CLONE:CLB-ID4,MABANTI-HUMAN
|
|
|
|
|
CD38,PLASMACELL,THYMOCYTE,T-CELLACTIVATED,GP45,CLONE:CLB-1D5,MABANTI-HUMAN
|
|
|
|
|
CD38,PLASMACELL,THYMOCYTE,T-CELLACTIVATED,CLONE:HI157,MABANTI-HUMAN,PE
|
|
|
|
|
CD38,PLASMACELL,T10ANTIGEN,45KD,CLONE:B307(AT1),MABANTI-HUMAN,FITC:FROZEN/NOPARAFFIN
|
|
|
|
|
CD38,PLASMACELL,CLONE:AT13/5,MABANTI-HUMAN,FITC:FLOW
|
|
|
|
|
CD38,PLASMACELL,CLONE:AT13/5,MABANTI-HUMAN
|
|
|
|
|
CD38,PLASMACELL,RATMABANTI-MOUSE,PE
|
|
|
|
|
CD38,PLASMACELL,RATMABANTI-MOUSE,BIOTIN
|
|
|
|
|
Cd36PlateletGpiv(ThrombospondinReceptor)
|
|
|
|
|
Cd41,PlateletGpiibIiia
|
|
|
|
|
CD9, Platelet, gp24, Clone: CLB-thromb/8, Mab anti-Human, FITC
|
|
|
|
|
CDPK2 protein
|
|
|
|
|
CDPK1 protein
|
|
|
|
|
CDPK3 protein
|
|
|
|
|
CDPKS, Syntide analog
|
|
|
|
|
CDPK substrate protein 1
|
|
|
|
cefmatilen
|
140128-74-1
|
C15H14N8O5S4
|
|
|
CefMenoxiMe Hcl Sterile
|
|
|
|
|
Cefmetazole Sodium/acid sterile
|
|
|
|
|
Cefmetazol
|
|
|
|
|
CEFMETAZOLE ACID
|
|
C15H17N7O5S3
|
|
Cefmepidium chloride
|
107452-79-9
|
C23H25N6O8S3.Cl
|
|
|
CEFMETZAOLE SODIUM
|
|
|